首页 | 本学科首页   官方微博 | 高级检索  
     

MAC预处理自体骨髓移植治疗急性白血病
引用本文:宋永平 魏旭东. MAC预处理自体骨髓移植治疗急性白血病[J]. 中华血液学杂志, 1996, 17(10): 513-515
作者姓名:宋永平 魏旭东
作者单位:河南医科大学第一附属医院
基金项目:河南省卫生厅青年科学研究基金
摘    要:
为评价MAC(马法兰、阿糖胞苷和环磷酰胺)预处理方案,应用该方案为17例急性白血病患者进行了自体骨髓移植。结果:该方案具有清除骨髓白血病细胞的作用,移植后全部患者造血功能获得重建,无一例移植相关死亡。中位随访18个月,5年无病生存率为50.5%,其中急性髓系白血病(AML)为61.2%。结果表明:MAC预处理方案对AML有良好疗效,且髓外毒副作用较轻,值得进一步试用。

关 键 词:白血病.急性,预处理方案,骨髓移植.自体

Melphalan,Ara-C and cyclophosphamide following autologous bone marrow transplantation for acute leukemia
Song Yongping,Wei Xudong,Zhou Dianbin,et al.. Melphalan,Ara-C and cyclophosphamide following autologous bone marrow transplantation for acute leukemia[J]. Chinese Journal of Hematology, 1996, 17(10): 513-515
Authors:Song Yongping  Wei Xudong  Zhou Dianbin  et al.
Abstract:
To evaluate the effect of MAC(Melphalan,Ara-C and Cyclophosphamide)conditioning regimen,17 patients with acute leukemia were treated with autologous bone marrow transplantation(ABMT)following MAC conditioning.The results showed that MAC had ablative effect on bone marrow and the hematopoiesis was completely reconstituted in all patients.No patients died of complications associated with transplantation.The disease-free-survival(DFS)at 5 years post-ABMT were 50.5%for all patients and 61.2% for acute myeloid leukemia(AML)at a median follow-up of 18 months.It is suggested that MAC protocol might be a safe,effective and economic conditioning regimen for ABMT in AML.
Keywords:Leukemia  acute Conditioning regimen Bone marrow Transplantation  autologous
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号